Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Detaylı Bibliyografya
Asıl Yazarlar:	Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL
Materyal Türü:	Conference item
Dil:	English
Baskı/Yayın Bilgisi:	Springer 2017

Benzer Materyaller

Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
Yazar:: Teoh, E, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
Yazar:: Scott, NP, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Cancer imaging with fluciclovine (18F)
Yazar:: Teoh, E
Baskı/Yayın Bilgisi: (2018)

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
Yazar:: Morotti, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Glutamine deprivation alters the origin and function of cancer cell exosomes
Yazar:: Fan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
Yazar:: Zuzana Balážová, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
Yazar:: Kirsten Margrete Selnæs, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Yazar:: Morotti, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
Yazar:: Ivar S Jensen, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Imaging Glioblastoma With 18F-Fluciclovine Amino Acid Positron Emission Tomography
Yazar:: Matthew L. Scarpelli, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas
Yazar:: Ephraim E. Parent, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
Yazar:: Tonghe Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis
Yazar:: Anna E. Garcia Whitlock, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis
Yazar:: Ephraim E. Parent, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells
Yazar:: Dyer, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Diagnostic accuracy of 18F-Fluciclovine PET/CT in primary lymph node staging of prostate cancer
Yazar:: R.J. Hoekstra, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
Yazar:: Morteza Esmaeili, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

The utilisation of glutamine and glucose by a 3-D tumour model trapped in quiescence
Yazar:: Smith, H, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Pharmacodynamic and pharmacokinetic markers for anti-angiogenic cancer therapy: Implications for dosing and selection of patients.
Yazar:: Morotti, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
Yazar:: Cato C. Loeff, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Quantification of Equivocal Findings in F18-Fluciclovine PET/CT Scans for Biochemical Recurrence of Localized Prostate Cancer
Yazar:: Daeun Sung, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis
Yazar:: Giuseppina Biscontini, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
Yazar:: Tore Bach-Gansmo, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.
Yazar:: Hsiu-Ni Kung, ve diğerleri
Baskı/Yayın Bilgisi: (2011-08-01)

Urinary glutamine/glutamate ratio as a potential biomarker of pediatric chronic intestinal pseudo-obstruction
Yazar:: Jun-Kai Yan, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning
Yazar:: Li Ma, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
Yazar:: Benjamin H. Lowentritt, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Complement susceptibility in glutamine deprived breast cancer cells
Yazar:: Boackle Robert J, ve diğerleri
Baskı/Yayın Bilgisi: (2007-07-01)

Therapeutic Potential of Glutamine Pathway in Lung Cancer
Yazar:: Enyu Tang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
Yazar:: Hui Li, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

#4. Elucidating the effect of glutamine metabolism in breast-to-bone metastasis
Yazar:: Breelyn Karno, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Texture Analysis in [<sup>18</sup>F]-Fluciclovine PET/CT Aids to Detect Prostate Cancer Biochemical Relapse: Report of a Preliminary Experience
Yazar:: Laura Travascio, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Advances in human glutamine-hydrolyzing synthetases and their therapeutic potential
Yazar:: Wen Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Glutamine and exercise
Yazar:: Mioko Nagashima, ve diğerleri
Baskı/Yayın Bilgisi: (2013-11-01)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Yazar:: Rui Ni, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
Yazar:: Andreas Julius Tulipan, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
Yazar:: Maria T. Grinde, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
Yazar:: Kawashima, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The duality between two-index potentials and the non-linear sigma model in field theory
Yazar:: Zois, I, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Leukemia Cells Resistant to Glutamine Deprivation Express Glutamine Synthetase Protein
Yazar:: Burcu Yücel, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)